Introduction of 101 China-based CROs/CMOs Serving Western Pharmaceutical and Biotechnology Industries
Book Details
Author(s)Inc. JZMed
PublisherMarketResearch.com
ISBN / ASINB002P4TZ64
ISBN-13978B002P4TZ68
AvailabilityAvailable for download now
MarketplaceUnited States 🇺🇸
Description
As Chinese pharmaceutical outsourcing service companies play more and more important roles in today’s world pharmaceutical outsourcing industry, it has become increasingly urgent for the Western pharmaceutical and biotechnology companies who plan to outsource any part of their drug discovery, development and manufacturing work to China, to have a complete collection of information with regards to the current service capabilities of the Chinese service providers in order for the outsourcing companies to work with a right partner in China whose service capability ideally matches the requirements of their outsourcing projects. This Introduction is thus designed and prepared to meet this urgent need by the outsourcing companies.
The Introduction compiles the complete information about the service scope and capabilities of 101 China-based service providers that are presently considered the strongest technically in China. These 101 China-based service providers are either capable of conducting contract pharmaceutical research and/or contract chemistry research for drug discovery and development, or have capability to conduct contract manufacturing of bulk materials [active pharmaceutical ingredients (APIs) and/or their intermediates] for drug candidates in development stages.
For each of these 101 China-based CROs/CMOs, the Introduction has examined a total of ten categories to measure their service capabilities. These criteria are considered most important for an outsourcing company to know when looking for a service provider in China.
They include:
The Introduction compiles the complete information about the service scope and capabilities of 101 China-based service providers that are presently considered the strongest technically in China. These 101 China-based service providers are either capable of conducting contract pharmaceutical research and/or contract chemistry research for drug discovery and development, or have capability to conduct contract manufacturing of bulk materials [active pharmaceutical ingredients (APIs) and/or their intermediates] for drug candidates in development stages.
For each of these 101 China-based CROs/CMOs, the Introduction has examined a total of ten categories to measure their service capabilities. These criteria are considered most important for an outsourcing company to know when looking for a service provider in China.
They include:
- 1) Company name
- 2) A full description of each provider’s service scope and capability
- 3) Comments about their service features and strengths
- 4) Their facility and capacity
- 5) Their in-house products (compound libraries) ready to offer
- 6) Customers each provider has served so far
- 7) Background of the provider company’s founder(s) or its current executive(s) including their scientific/education merits and work experiences
- 8) Year the company was founded
- 9) Current number of technical employees including the percentage of senior (such as Ph.D.) level scientists to reflect their real technical strength
- 10) A complete collection of their contact information including physical and mailing address as well as e-mail addresses, phone and fax numbers, website addresses, and the addresses of their branches or divisions in other places than their headquarters.
- Where can I find these Chinese service providers?
- How do I know what services they are currently offering?
- How good is each of them?
- How do I know whether they can handle my projects?
- Which one could best meet the requirements of my outsourcing projects?
- Where are they located in China?
- How to approach them?
